SORGEM Evaluation carried out the independent valuation in connection with the public offer, potentially followed by a rights issue, by Auroralux SAS (a subsidiary of PAI Partners) for the shares of Amplitude Surgical

Amplitude Surgical develops and markets prostheses, implants and associated products (ancillary devices, computer-assisted surgery systems, etc.) for orthopaedic surgery, covering the main conditions affecting the hip, knee and extremities (foot and ankle).

Pursuant to Article L.621-8 of the Monetary and Financial Code and Article 231-26 of its General Regulations, the AMF, pursuant to its compliance decision of 5 January 2021, affixed approval mark No. 21-002, dated 5 January 2021, to the prospectus.